Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nutriband ( (NTRB) ) has issued an announcement.
Nutriband Inc. has secured a full patent from the Chinese National Intellectual Property Administrant for its innovative “Abuse and Misuse Deterrent Transdermal System” related to their AVERSA™ technology. This development is pivotal for 4p Therapeutics’ system, which employs taste aversion to combat opioid patch abuse. The AVERSA™ technology aims to enhance the safety of transdermal drugs like fentanyl by preventing misuse while preserving access for patients in need. Nutriband’s technology spans a global patent portfolio, reflecting its potential impact on the pharmaceutical market.
Learn more about NTRB stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money